TrialCritical care (London, England)2024

Seven versus 14 days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trial.

Beatriz Arns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.